A new pancreatic cancer vaccine has been found to be safe and successful in reaching immune system cells, with several patients remaining disease-free over 30 months after diagnosis. The vaccine uses lab-grown pancreatic cancer cells genetically-modified with the immune-boosting gene GM-CSF.
Researchers found that IL-7 increases in response to declining CD4+ cell counts, a hallmark of HIV disease. This cytokine stimulates the thymus and other immune tissues to produce new T-cells, potentially rebuilding the entire T-cell compartment.
A new study by University of North Carolina researchers finds that financial factors are a major contributor to the racial disparities in mammography rates among black women. The study, which controlled for other variables, found that black women who received a recommendation for mammography were more likely to have health insurance an...